comparemela.com
Home
Live Updates
Promising disease modifying approach to Duchenne muscular dystrophy with Neu-REFIX® Beta 1,3-1,6 glucan* from Japan; the first such clinical report. : comparemela.com
Promising disease modifying approach to Duchenne muscular dystrophy with Neu-REFIX® Beta 1,3-1,6 glucan* from Japan; the first such clinical report.
TOKYO--(BUSINESS WIRE)--Aug 4, 2023--
Related Keywords
Japan ,
United States ,
Texas ,
Japanese ,
Naoki Yamamoto ,
Samuel Jk Abraham ,
Aureobasidium Pullulans ,
International Holding Group ,
Gn Corporation Co Ltd ,
Muscular Dystrophy ,
Business Wire ,
Holding Group ,
Limb Girdle Muscle Dystrophy ,
comparemela.com © 2020. All Rights Reserved.